Hologic Inc (HOLX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Hologic Inc  (NASDAQ: HOLX)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Hologic Inc Profitability Comparisons

Select each Category to receive further Information




HOLX Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q4 MRQ) 64.62 % 42.39 % 71.46 % 55.11 %
Gross Margin (Q4 TTM) 58.27 % 43.72 % 68.39 % 49.4 %
Gross Profit Margin 5 Yr. Avg. 81.88 % 44.06 % 65.56 % 47.82 %
EBITDA Margin (Q4 MRQ) 33.85 % 11.68 % 22.25 % 23.73 %
EBITDA Margin (Q4 TTM) 30.54 % 13.24 % 19.16 % 20.39 %
EBITDA Margin 5 Yr. Avg. 49.84 % 15.11 % 31.56 % 22.44 %
Operating Margin (Q4 MRQ) 26.12 % 6.82 % 19.05 % 20.92 %
Operating Margin (Q4 TTM) 19.8 % 7.68 % 15.8 % 17.7 %
Operating Margin 5 Yr. Avg. 36.81 % 8.63 % 14.33 % 17.24 %
Pre-Tax Profit Margin (Q4 MRQ) 25.31 % 5.5 % 14.98 % 12.27 %
Pre-Tax Profit Margin (Q4 TTM) 18.2 % 6.32 % 13.04 % 12.46 %
Pre-Tax Profit Margin 5 Yr. Avg. 35.77 % 7.36 % 10.37 % 12.42 %
Net Margin (Q4 MRQ) 19.74 % 4.01 % 12.95 % 10.15 %
Net Margin (Q4 TTM) 14.92 % 4.47 % 14.99 % 10.36 %
Net Margin 5 Yr. Avg. 28.92 % 5.18 % 6.08 % 9.9 %



Business Segment Profit Margin
 
United States
  Explore United States Segment  -
International
  Explore International Segment  -
Diagnostics
  Explore Diagnostics Segment  -
Diagnostics United States
  Explore Diagnostics United States Segment  -
Diagnostics International
  Explore Diagnostics International Segment  -
Diagnostics Cytology Perinatal
  Explore Diagnostics Cytology Perinatal Segment  -
Diagnostics Cytology Perinatal United States
  Explore Diagnostics Cytology Perinatal United States Segment  -
Diagnostics Cytology Perinatal International
  Explore Diagnostics Cytology Perinatal International Segment  -
Diagnostics Molecular Diagnostics
  Explore Diagnostics Molecular Diagnostics Segment  -
Diagnostics Molecular Diagnostics United States
  Explore Diagnostics Molecular Diagnostics United States Segment  -
Diagnostics Molecular Diagnostics International
  Explore Diagnostics Molecular Diagnostics International Segment  -
Diagnostics Blood Screening
  Explore Diagnostics Blood Screening Segment  -
Diagnostics Blood Screening United States
  Explore Diagnostics Blood Screening United States Segment  -
Breast Health
  Explore Breast Health Segment  -
Breast Health United States
  Explore Breast Health United States Segment  -
Breast Health International
  Explore Breast Health International Segment  -
Breast Health Breast Imaging
  Explore Breast Health Breast Imaging Segment  -
Breast Health Breast Imaging United States
  Explore Breast Health Breast Imaging United States Segment  -
Breast Health Breast Imaging International
  Explore Breast Health Breast Imaging International Segment  -
Breast Health Interventional Breast Solutions
  Explore Breast Health Interventional Breast Solutions Segment  -
Breast Health Interventional Breast Solutions United States
  Explore Breast Health Interventional Breast Solutions United States Segment  -
Breast Health Interventional Breast Solutions International
  Explore Breast Health Interventional Breast Solutions International Segment  -
GYN Surgical
  Explore GYN Surgical Segment  -
GYN Surgical United States
  Explore GYN Surgical United States Segment  -
GYN Surgical International
  Explore GYN Surgical International Segment  -
Skeletal Health
  Explore Skeletal Health Segment  -
Skeletal Health United States
  Explore Skeletal Health United States Segment  -
Skeletal Health International
  Explore Skeletal Health International Segment  -
Europe
  Explore Europe Segment  -
Asia-Pacific
  Explore Asia-Pacific Segment  -
Rest of World
  Explore Rest of World Segment  -
Disposables
  Explore Disposables Segment  -
Capital equipment components and software
  Explore Capital equipment components and software Segment  -
Service
  Explore Service Segment  -
Other
  Explore Other Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q4 MRQ) 23.72 % 1.71 % 0.33 % 0.45 %
Free Cash Flow Margin (Q4 TTM) 28.56 % 7.71 % 13.32 % 10.6 %
Free Cash Flow Margin 5 Yr. Avg. - 10.67 % 15.07 % 14.29 %
Net Cash Flow Margin (Q4 MRQ) 22.98 % -4.83 % 0.14 % 0.2 %
Net Cash Flow Margin (Q4 TTM) 10.59 % 5.23 % 2.53 % 9.55 %
Net Cash Flow Margin 5 Yr. Avg. - 1.3 % 3.19 % 5.94 %
Effective Tax Rate (Q4 MRQ) 22.03 % 26.44 % 13.56 % 17.37 %
Effective Tax Rate (Q4 TTM) 18.03 % 29.25 % 20.16 % 19.86 %
Effective Tax Rate 5 Yr. Avg. 19.42 % 35.11 % 20.51 % 19.82 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.